These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 18987623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.
    AIDS; 2009 Apr 27; 23(7):825-33. PubMed ID: 19307941
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.
    Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E, Cotter A, Purswani M, PACTG 394 Study Team.
    Antimicrob Agents Chemother; 2011 Dec 27; 55(12):5914-22. PubMed ID: 21896911
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
    Colbers AP, Hawkins DA, Gingelmaier A, Kabeya K, Rockstroh JK, Wyen C, Weizsäcker K, Sadiq ST, Ivanovic J, Giaquinto C, Taylor GP, Moltó J, Burger DM, PANNA network.
    AIDS; 2013 Mar 13; 27(5):739-48. PubMed ID: 23169329
    [Abstract] [Full Text] [Related]

  • 6. Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).
    Hirt D, Pruvost A, Ekouévi DK, Urien S, Arrivé E, Kone M, Nerrienet E, Nyati M, Gray G, Kruy LS, Blanche S, Dabis F, Tréluyer JM.
    Antimicrob Agents Chemother; 2011 Jun 13; 55(6):2953-60. PubMed ID: 21464241
    [Abstract] [Full Text] [Related]

  • 7. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
    Nurutdinova D, Onen NF, Hayes E, Mondy K, Overton ET.
    Ann Pharmacother; 2008 Nov 13; 42(11):1581-5. PubMed ID: 18957630
    [Abstract] [Full Text] [Related]

  • 8. Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2).
    Hirt D, Ekouévi DK, Pruvost A, Urien S, Arrivé E, Blanche S, Avit D, Amani-Bosse C, Nyati M, Legote S, Ek ML, Say L, McIntyre J, Dabis F, Tréluyer JM.
    Antimicrob Agents Chemother; 2011 Jun 13; 55(6):2961-7. PubMed ID: 21464249
    [Abstract] [Full Text] [Related]

  • 9. Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.
    Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, Grau E, García E, Moltó J, Grassi J, Clotet B.
    Antimicrob Agents Chemother; 2005 May 13; 49(5):1907-14. PubMed ID: 15855513
    [Abstract] [Full Text] [Related]

  • 10. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
    Ripamonti D, Cattaneo D, Maggiolo F, Airoldi M, Frigerio L, Bertuletti P, Ruggeri M, Suter F.
    AIDS; 2007 Nov 30; 21(18):2409-15. PubMed ID: 18025877
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.
    Nirogi R, Bhyrapuneni G, Kandikere V, Muddana N, Saralaya R, Komarneni P, Mudigonda K, Mukkanti K.
    Biopharm Drug Dispos; 2012 Jul 30; 33(5):265-77. PubMed ID: 22610784
    [Abstract] [Full Text] [Related]

  • 12. Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.
    TEmAA ANRS 12109 Study GroupINSERM U897, Universite´ Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France. elise.arrive@isped.u-bordeaux2.fr, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Avit D, Kruy LS, McIntyre J, Say L, Gray G, Ekouévi DK, Dabis F.
    AIDS; 2010 Oct 23; 24(16):2481-8. PubMed ID: 20827166
    [Abstract] [Full Text] [Related]

  • 13. Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.
    Tong L, Phan TK, Robinson KL, Babusis D, Strab R, Bhoopathy S, Hidalgo IJ, Rhodes GR, Ray AS.
    Antimicrob Agents Chemother; 2007 Oct 23; 51(10):3498-504. PubMed ID: 17664327
    [Abstract] [Full Text] [Related]

  • 14. Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers.
    Blum MR, Chittick GE, Begley JA, Zong J.
    J Clin Pharmacol; 2007 Jun 23; 47(6):751-9. PubMed ID: 17519400
    [Abstract] [Full Text] [Related]

  • 15. Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.
    Ramanathan S, Cheng A, Mittan A, Ebrahimi R, Kearney BP.
    J Clin Pharmacol; 2006 May 23; 46(5):559-66. PubMed ID: 16638739
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y, Livingston E, Patil S, McKinney RE, Bardeguez AD, Gandia J, O'Sullivan MJ, Clax P, Huang S, Unadkat JD.
    J Infect Dis; 1999 Nov 23; 180(5):1536-41. PubMed ID: 10515813
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.
    Benaboud S, Ekouévi DK, Urien S, Rey E, Arrivé E, Blanche S, Gray G, Sim KL, Avit D, McIntyre J, Nerrienet E, Dabis F, Tréluyer JM, Hirt D, TEmAA ANRS 12109 Study Group.
    Antimicrob Agents Chemother; 2011 Jan 23; 55(1):331-7. PubMed ID: 20956588
    [Abstract] [Full Text] [Related]

  • 18. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP, Mathias A.
    Pharmacotherapy; 2009 Aug 23; 29(8):924-9. PubMed ID: 19637945
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques.
    Van Rompay KK, Hamilton M, Kearney B, Bischofberger N.
    Antimicrob Agents Chemother; 2005 May 23; 49(5):2093-4. PubMed ID: 15855535
    [Abstract] [Full Text] [Related]

  • 20. Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases.
    Sabbatini F, Prati F, Borghi V, Bedini A, Esposito R, Mussini C.
    Infection; 2007 Dec 23; 35(6):474-6. PubMed ID: 18034206
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.